UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 10, 2007
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
Florida 0-11102 59-1564329
(State or Other Jurisdiction (Commission File Number) I.R.S. Employer
of Incorporation) Identification No.)
4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address of principal executive office Zip Code)
(954) 587-6280
Registrant's telephone number, including area code:
Not Applicable
(Former name or former address, if changes since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure:
Effective January 8, 2007 we commenced shipping against open Purchase
Orders to Wal-Mart which increases our product distribution and the chain-wide
store count of units offering our line. Wal-Mart, a longstanding customer will
carry an increased assortment of our products, featuring their introduction of
our Fuel Additive, StarTron products, in approximately 2,700 retail outlets,
many of which did not previously carry any of our products. Our StarTron
products are gaining national consumer recognition and we expect to aggressively
promote these items during the current year in order to more fully develop their
potential.
We have modified our short and long term manufacturing production plans to
include retail "sell-through" projections presented to us by Wal-Mart. Although
the financial impact of the expanded distribution for the remaining months of
the year ending December 31, 2007 cannot be ascertained at this time, we will
publicly disclose our progress in this regard in prospective filings with the
Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Ocean Bio-Chem, Inc.
January 10, 2007 /s/ Peter G. Dornau
-----------------------------
Peter G. Dornau
President and
Chief Executive Officer